Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $4.34 in the prior trading day, Achieve Life Sciences Inc (NASDAQ: ACHV) closed at $4.32, down -0.46%. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 0.59 million shares were traded. ACHV stock price reached its highest trading level at $4.385 during the session, while it also had its lowest trading level at $4.25.
Ratios:
Our goal is to gain a better understanding of ACHV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.14 and its Current Ratio is at 5.14. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In the most recent recommendation for this company, Citizens JMP on November 25, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $19.
On August 21, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12. On November 14, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $12.Rodman & Renshaw initiated its Buy rating on November 14, 2024, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 18 ’25 when Oki Mark K sold 50,060 shares for $2.92 per share. The transaction valued at 146,175 led to the insider holds 127,940 shares of the business.
Stewart Richard Alistair sold 129,501 shares of ACHV for $378,143 on Sep 18 ’25. The Chief Executive Officer now owns 228,875 shares after completing the transaction at $2.92 per share. On Sep 04 ’25, another insider, Wan Jerry, who serves as the Principal Accounting Officer of the company, sold 14,070 shares for $2.77 each. As a result, the insider received 38,974 and left with 32,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 229970832 and an Enterprise Value of 191814832.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.74, which has changed by 0.1428572 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.78, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is -3.81%, while the 200-Day Moving Average is calculated to be 33.40%.
Shares Statistics:
The stock has traded on average 1.21M shares per day over the past 3-months and 491390 shares per day over the last 10 days, according to various share statistics. A total of 52.81M shares are outstanding, with a floating share count of 46.63M. Insiders hold about 12.41% of the company’s shares, while institutions hold 40.05% stake in the company. Shares short for ACHV as of 1764288000 were 6380019 with a Short Ratio of 5.29, compared to 1761868800 on 6095362. Therefore, it implies a Short% of Shares Outstanding of 6380019 and a Short% of Float of 13.99.
Earnings Estimates
The market rating of Achieve Life Sciences Inc (ACHV) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.25 and low estimates of -$0.43.
Analysts are recommending an EPS of between -$1.22 and -$1.3 for the fiscal current year, implying an average EPS of -$1.26. EPS for the following year is -$1.17, with 6.0 analysts recommending between -$0.84 and -$1.37.
